Professor Bart De Strooper is the founding director of the UK Dementia Research Institute (UK DRI).

He is a researcher in Alzheimer's disease, and supervises laboratories based in the UK DRI at the Francis Crick Institute in London and in the VIB laboratory at the KU Leuven in Belgium.

Bart De Strooper’s research is focussed on translating genetic findings into mechanisms of neurodegenerative diseases and drug targets. He is best known for his work on the presenilins and gamma-secretase, and more recently for his work on the cellular theory of Alzheimer’s Disease.  He was elected to the Academy of Medical Sciences Fellowship in 2020, and has received several awards including the Potamkin prize, the Metlife Foundation Award for Medical Research, Alois Alzheimer’s prize, the highly prestigious Brain Prize 2018 and Commander in the Order of Leopold I.

Qualifications and history

1991
KU Leuven
PhD
1994
EMBL-Heidelberg, Germany
Visiting researcher
2000
KU Leuven
Professor of Medicine
2002
VIB - Vlaams Instituut voor Biotechnologie
Assistant Director of the Deparment of Molecular Genetics
2007
VIB Center for the Biology of Disease
Departmental Director
2010
leuven Research Institute of Neurodegenerative Diseases
Founder and Co-Director of LIND
2013
University College, London, UK
Professor of Neurodegenerative Diseases
2017
UK Dementia Research Institute
Director
Displaying 1 - 3 of 3
Last updated : 28 March 2024 02:21